Nature's Sunshine Q3 net sales fall 9% to $116.6 million; full-year outlook cut
Nature's Sunshine reported third-quarter 2026 net sales down 9% to $116.6 million, and GAAP net income attributable to common shareholders fell to $1.9 million, or $0.11 per diluted share, from $5.3 million, or $0.30. The company cut its full-year 2026 guidance for net sales and adjusted EBITDA, citing a stronger U.S. dollar and challenges in China.
Key points
- Net sales fell 9% to $116.6 million (down 7% excluding currency effects); Asia net sales fell 14.9% to $55.1 million
- Full-year 2026 net sales outlook lowered to $460-470 million from $490-500 million
- Full-year 2026 adjusted EBITDA outlook lowered to $44-48 million from $48-52 million
- As of September 30, 2026, cash and cash equivalents were $89.4 million and the company had zero debt
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.